Point72 Asset Management’s Applied Therapeutics APLT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-17,020
| Closed | -$1.7K | – | 3755 |
|
|
2025
Q4 | $1.7K | Buy |
+17,020
| New | +$10.8K | ﹤0.01% | 3860 |
|
|
2024
Q1 | – | Sell |
-474,929
| Closed | -$1.59M | – | 2151 |
|
|
2023
Q4 | $1.59M | Hold |
474,929
| – | – | ﹤0.01% | 1282 |
|
|
2023
Q3 | $1.18M | Hold |
474,929
| – | – | ﹤0.01% | 1278 |
|
|
2023
Q2 | $608K | Sell |
474,929
-245,009
| -34% | -$325K | ﹤0.01% | 1229 |
|
|
2023
Q1 | $584K | Hold |
719,938
| – | – | ﹤0.01% | 1205 |
|
|
2022
Q4 | $547K | Sell |
719,938
-1,000,000
| -58% | -$791K | ﹤0.01% | 1138 |
|
|
2022
Q3 | $1.6M | Sell |
1,719,938
-1,115,062
| -39% | -$1.34M | 0.01% | 979 |
|
|
2022
Q2 | $2.69M | Buy |
2,835,000
+286,000
| +11% | +$468K | 0.01% | 873 |
|
|
2022
Q1 | $5.38M | Buy |
2,549,000
+1,435,000
| +129% | +$3.84M | 0.02% | 688 |
|
|
2021
Q4 | $9.97M | Buy |
1,114,000
+98,729
| +10% | +$1.3M | 0.04% | 514 |
|
|
2021
Q3 | $16.9M | Buy |
1,015,271
+522,771
| +106% | +$9.03M | 0.07% | 356 |
|
|
2021
Q2 | $10.2M | Buy |
492,500
+194,200
| +65% | +$3.68M | 0.05% | 447 |
|
|
2021
Q1 | $5.59M | Buy |
298,300
+138,300
| +86% | +$2.98M | 0.03% | 546 |
|
|
2020
Q4 | $3.52M | Buy |
160,000
+38,386
| +32% | +$799K | 0.02% | 643 |
|
|
2020
Q3 | $2.52M | Sell |
121,614
-107,110
| -47% | -$2.78M | 0.01% | 673 |
|
|
2020
Q2 | $8.27M | Sell |
228,724
-300,750
| -57% | -$12.6M | 0.05% | 381 |
|
|
2020
Q1 | $17.3M | Buy |
+529,474
| New | +$21.4M | 0.14% | 214 |
|
Point72 Asset Management's APLT Position: Q1 2026 in Review
Point72 Asset Management sold out of Applied Therapeutics (APLT) in Q1 2026, closing a stake of 17,020 shares — an estimated $1.7K sold.
Point72 Asset Management first reported a position in APLT in Q1 2020 and held it in 17 quarters. The position peaked at $17.3M in Q1 2020. 0 funds tracked by Wall St. Rank hold APLT as of Q1 2026.
- Point72 Asset Management reported no remaining Applied Therapeutics position as of Q1 2026 after selling out during the quarter.
- Point72 Asset Management sold 17,020 Applied Therapeutics shares in Q1 2026, an estimated $1.7K.
- Point72 Asset Management first reported a position in Applied Therapeutics in Q1 2020 and held it in 17 quarters.
- Point72 Asset Management's Applied Therapeutics position peaked at $17.3M in Q1 2020.
- 0 funds tracked by Wall St. Rank held Applied Therapeutics as of Q1 2026.
Based on Point72 Asset Management's 13F filing for Q1 2026, filed 15 May 2026.